Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Company Comment

    Lessons From The Great Investors… On Coca-Cola And AstraZeneca plc

    | Mark Stones

    AstraZeneca plc (LON: AZN) and Coca-Cola are the quintessential investments of two of the all-time greats.

    Read more »

    Company Comment

    What You Need To Know About AstraZeneca plc Rejecting Pfizer’s Final Offer

    | Mark Stones

    AstraZeneca plc (LON: AZN) will live on as a standalone entity with ambitious revenue targets and a buzzing drugs pipeline.

    Read more »

    Investing Articles

    Investors Should Be Careful Around AstraZeneca plc

    | Rupert Hargreaves

    With opposition against the Pfizer-AstraZeneca plc (LON: AZN) deal growing, investors need to be careful.

    Read more »

    Investing Articles

    How AstraZeneca plc Could Struggle To Repeat A 5-Year Gain of 78%

    | G A Chester

    AstraZeneca plc (LON:AZN) could loose a third of its value in the next five years.

    Read more »

    Investing Articles

    AstraZeneca plc Is In Play And I’m Holding Out For More

    | Malcolm Wheatley

    What might be the impact on your wealth if Pizfer buys AstraZeneca plc (LON:AZN)?

    Read more »

    Investing Articles

    What Could Pfizer-AstraZeneca Be Like?

    | Prabhat Sakya

    What might be the positives from this potential takeover?

    Read more »

    Company Comment

    Would A Combined AstraZeneca plc/Pfizer Inc. Be Worth Owning?

    | Mark Stones

    AstraZeneca plc's (LON: AZN) strengths as a separate entity won't be best harnessed by Pfizer Inc. (NYSE:PFE)

    Read more »

    Investing Articles

    Is The Pfizer Takeover Offer for AstraZeneca plc ‘Un-American’?

    | Lisa Walls-Hester

    Pfizer Inc. (NYSE:PFE) has AstraZeneca plc (LON:AZN) firmly in its sights as a home for the $69bn of earnings it…

    Read more »

    Investing Articles

    What Dividend Hunters Need To Know About AstraZeneca plc

    | Royston Wild

    Royston Wild looks at whether AstraZeneca plc (LON: AZN) is an attractive income stock.

    Read more »

    Investing Articles

    AstraZeneca plc CEO’s Sweet Spot

    | Alessandro Pasetti

    AstraZeneca plc (LON:AZN) CEO Pascal Soriot should ask for more because Pfizer Inc. (NYSE:PFE) could go hostile...

    Read more »

    Investing Videos

    What Should You Do With Your AstraZeneca plc Shares?

    | Nate Weisshaar

    VIDEO: Two Fools put AstraZeneca plc (LON:AZN) under the spotlight.

    Read more »

    Investing Articles

    Could Shire PLC And Hikma Pharmaceuticals Plc Be The Next Pharma Takeover Targets?

    | G A Chester

    AstraZeneca plc (LON:AZN) is in play, and Shire PLC (LON:SHP) and Hikma Pharmaceuticals Plc (LON:HIK) now look ripe for bids.

    Read more »